Pharmacogenetics. Gene mutation may boost risk of heart arrhythmias.
Jean
J
Marx
D000959:Antihypertensive Agents / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000235:genetics*; D044383:Black People / Q000235:genetics*; D004232:Diuretics / Q000009:adverse effects; D005260:Female; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D062554:NAV1.5 Voltage-Gated Sodium Channel; D010597:Pharmacogenetics; D017354:Point Mutation; D012307:Risk Factors; D015222:Sodium Channels / Q000235:genetics* / Q000378:metabolism
D000959:Antihypertensive Agents; D004232:Diuretics; D062554:NAV1.5 Voltage-Gated Sodium Channel; C568320:SCN5A protein, human; D015222:Sodium Channels